UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer

Molecules (Basel, Switzerland), 2018-08, Vol.23 (9), p.2191

2018

Volltextzugriff (PDF)

FunRich: An open access standalone functional enrichment and interaction network analysis tool

Proteomics (Weinheim), 2015-08, Vol.15 (15), p.2597-2601

2015

Volltextzugriff (PDF)

HDACs and HDAC inhibitors in colon cancer

Epigenetics, 2008-01, Vol.3 (1), p.28-37

Mariadason, John M.

2008

Volltextzugriff (PDF)

Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer

Cancer research (Chicago, Ill.), 2014-06, Vol.74 (12), p.3238-3247

2014

Volltextzugriff (PDF)

Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity

Nature communications, 2019-11, Vol.10 (1), p.5291-14, Article 5291

2019

Volltextzugriff (PDF)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

BMC cancer, 2022-05, Vol.22 (1), p.478-478, Article 478

2022

Volltextzugriff (PDF)

Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer

The Journal of biological chemistry, 2006-05, Vol.281 (19), p.13548-13558

2006

Volltextzugriff (PDF)

Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells

Molecular cancer therapeutics, 2016-06, Vol.15 (6), p.1217-1226

2016

Volltextzugriff (PDF)

PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab

Cancer research (Chicago, Ill.), 2008-03, Vol.68 (6), p.1953-1961

2008

Volltextzugriff (PDF)

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

Clinical cancer research, 2021-04, Vol.27 (8), p.2159-2167

2021

Volltextzugriff (PDF)

Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells

PloS one, 2014-03, Vol.9 (3), p.e88950-e88950

2014

Volltextzugriff (PDF)

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

Molecular cancer, 2017-06, Vol.16 (1), p.112-112, Article 112

2017

Volltextzugriff (PDF)

Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (14), p.5901-5911

2010

Volltextzugriff (PDF)

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

Antioxidants & redox signaling, 2015-07, Vol.23 (1), p.66-84

2015

Volltextzugriff (PDF)

Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles

Pharmaceutics, 2018-12, Vol.10 (4), p.283

2018

Volltextzugriff (PDF)

ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types

Clinical cancer research, 2017-09, Vol.23 (18), p.5573-5584

2017

Volltextzugriff (PDF)

Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer

Biomedicines, 2024-05, Vol.12 (5), p.1117

2024

Volltextzugriff (PDF)

Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis

Scientific reports, 2023-02, Vol.13 (1), p.2422-2422, Article 2422

2023

Volltextzugriff (PDF)

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer

Scientific reports, 2022-01, Vol.12 (1), p.1238-1238, Article 1238

2022

Volltextzugriff (PDF)

Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1505-1512

2012

Volltextzugriff (PDF)

By moonlighting in the nucleus, villin regulates epithelial plasticity

Molecular biology of the cell, 2016-02, Vol.27 (3), p.535-548

2016

Volltextzugriff (PDF)

Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer

Frontiers in oncology, 2022-10, Vol.12, p.1018767-1018767

2022

Volltextzugriff (PDF)

The Intestinal Epithelial Cell Differentiation Marker Intestinal Alkaline Phosphatase (ALPi) Is Selectively Induced by Histone Deacetylase Inhibitors (HDACi) in Colon Cancer Cells in a Kruppel-like Factor 5 (KLF5)-dependent Manner

The Journal of biological chemistry, 2014-09, Vol.289 (36), p.25306-25316

2014

Volltextzugriff (PDF)

Paneth cell marker expression in intestinal villi and colon crypts characterizes dietary induced risk for mouse sporadic intestinal cancer

Proceedings of the National Academy of Sciences - PNAS, 2011-06, Vol.108 (25), p.10272-10277

2011

Volltextzugriff (PDF)

Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment

Clinical cancer research, 2015-08, Vol.21 (16), p.3695-3704

2015

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(148)

Publikationsform

Artikel
(162)

Sprache

Englisch
(162)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer

FunRich: An open access standalone functional enrichment and interaction network analysis tool

HDACs and HDAC inhibitors in colon cancer

Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer

Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer

Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells

PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles

ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types

Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer

Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer

Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer

By moonlighting in the nucleus, villin regulates epithelial plasticity

Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer

The Intestinal Epithelial Cell Differentiation Marker Intestinal Alkaline Phosphatase (ALPi) Is Selectively Induced by Histone Deacetylase Inhibitors (HDACi) in Colon Cancer Cells in a Kruppel-like Factor 5 (KLF5)-dependent Manner

Paneth cell marker expression in intestinal villi and colon crypts characterizes dietary induced risk for mouse sporadic intestinal cancer

Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment

Suchergebnisse filtern